By 
Catherine Wood, chief executive officer of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, Oct. 18, 2021.
Kyle Grillot | Bloomberg | Getty Images
Gene-editing stocks may have disappointed lately but Cathie Wood still sees them as a big opportunity for long-term investors, and highlighted three favorites.
Comments